Health-related quality of life of women after HPV testing as triage strategy for an abnormal Pap smear: a nested randomized pragmatic trial in a middle-income country

Qual Life Res. 2020 Nov;29(11):2999-3008. doi: 10.1007/s11136-020-02563-w. Epub 2020 Jul 2.

Abstract

Background: Information obtained in studies on the impact of human papilloma virus (HPV) testing on health-related quality of life is contradictory.

Objective: To assess the impact on health-related quality of life of the HPV test, colposcopy, and cytology as triage strategies after a cytology with atypical squamous cells of undetermined significance (ASCUS) in Medellín, Colombia.

Methods: We carried out a nested analysis on the randomized pragmatic trial (ASCUS-COL). Women with ASCUS were assigned randomly to one of the 3 arms (Pap smear, colposcopy, HPV). Participants completed a questionnaire at baseline, two weeks after receiving the results of the triage tests and one year after the second questionnaire. We used the SF-36 to assess health-related quality of life.

Results: The sum score of the physical health component (PHC) and mental health component (MHC) increased significantly over time for the whole sample and there were no statistically significant differences between arms of PHC = survey 1: mean 52.4 (SD 8.21) vs. survey 3: mean 54.4 (SD 8.16) p < 0.0001 and of MHC = survey 1: mean 44.9 (SD 11.72) vs. survey 3: mean 48.1 (SD 11.20) p < 0.0001. A lower MHC occurred in women with lesser schooling, belonging to the public health care regimen, higher number of live births, and separated. A lower PHC was associated with the cytology arm, higher age, lesser schooling, and belonging to the subsidized regime. The risk of having depression went from 42% in the first survey to 26% in the third.

Conclusion: The triage strategies affected health-related quality of life in the same manner. ClinicalTrials.gov Identifier: NCT02067468.

Keywords: Atypical squamous cells of undetermined significance (ASCUS); Health-related quality of life (HRQoL); Human papilloma virus (HPV).

MeSH terms

  • Adult
  • Female
  • Humans
  • Middle Aged
  • Papanicolaou Test / methods*
  • Papillomaviridae / genetics
  • Papillomaviridae / pathogenicity*
  • Papillomavirus Infections / diagnosis*
  • Quality of Life / psychology*
  • Triage / methods*
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT02067468